SEPN
Septerna, Inc. Common Stock
NASDAQ: SEPN · HEALTHCARE · BIOTECHNOLOGY
$23.76
+1.32% today
Updated 2026-04-30
Market cap
$1.05B
P/E ratio
—
P/S ratio
22.92x
EPS (TTM)
$-1.10
Dividend yield
—
52W range
$6 – $33
Volume
0.3M
Septerna, Inc. Common Stock (SEPN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | $36.12M | $130.87M | $456.55M |
| Cash & equivalents | $30.61M | $88.48M | $238.20M |
| Current assets | $31.89M | $112.68M | $356.82M |
| Total liabilities | $80.32M | $169.24M | $36.51M |
| Current liabilities | $5.54M | $6.91M | $12.85M |
| Long-term debt | — | — | — |
| Shareholder equity | $-44.20M | $-38.37M | $420.05M |
| Retained earnings | $-50.76M | $-46.58M | $-118.37M |
| Accounts receivable | $0.00 | $22.78M | $1.12M |
| Inventory | — | — | — |
| Goodwill | — | — | — |